NBOMe & Ketamine
NBOMe compounds are a class of synthetic psychedelic substances that primarily act as potent serotonin 5-HT2A receptor agonists. They are structurally related to the 2C family of phenethylamines but are modified with a 2-methoxybenzyl (NBOMe) group, which significantly increases their receptor binding affinity and potency. This modification allows them to be active at microgram doses, making them among the most potent hallucinogens known.
The most well-known NBOMe compounds include 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe, named for their substitution at the 4-position of the phenyl ring. 25I-NBOMe has an iodine atom, 25C-NBOMe has a chlorine atom, and 25B-NBOMe has a bromine atom, which influences their pharmacokinetics and subjective effects. These substances are full agonists at the 5-HT2A receptor, meaning they strongly activate these receptors, leading to intense psychedelic effects. Their high potency differentiates them from classical psychedelics like LSD or psilocybin, which are only partial agonists at the same receptor.
When an NBOMe compound binds to the 5-HT2A receptor, it initiates a cascade of intracellular signaling events that alter neuronal activity and network connectivity. This results in profound changes in perception, thought patterns, and emotional states. Users typically experience visual hallucinations, pattern recognition enhancement, and altered time perception. Compared to classical psychedelics, NBOMe compounds often have a more stimulating and less introspective character, with a greater likelihood of inducing anxiety, paranoia, and vasoconstriction.
NBOMe compounds also interact with 5-HT2C and 5-HT2B receptors, which may contribute to their cardiovascular effects. Unlike LSD, which has a relatively safe physiological profile, NBOMe compounds can cause significant vasoconstriction, leading to increased blood pressure, tachycardia, and, in severe cases, ischemia or organ damage.
Metabolism of NBOMe compounds occurs primarily in the liver, where they are broken down by cytochrome P450 enzymes. The metabolic rate varies between individuals, influencing the duration and intensity of effects. Unlike some other psychedelics, NBOMe compounds are known for having a bitter and numbing taste, a characteristic that has been used to distinguish them from LSD, which is usually tasteless.
Ketamine is a dissociative anesthetic that primarily acts as an N-methyl-D-aspartate (NMDA) receptor antagonist. By blocking these glutamate-gated ion channels, ketamine disrupts excitatory neurotransmission in the brain, leading to altered perception, analgesia, and dissociation. The NMDA receptor plays a critical role in synaptic plasticity, learning, and memory, so its inhibition results in cognitive and sensory detachment, a hallmark of ketamine’s effects.
In addition to NMDA antagonism, ketamine influences several other neurotransmitter systems. It increases glutamate release in the prefrontal cortex by inhibiting inhibitory gamma-aminobutyric acid (GABA) interneurons, leading to enhanced synaptic activity in excitatory circuits. This paradoxical increase in glutamate transmission, despite NMDA blockade, contributes to ketamine’s rapid antidepressant effects by promoting neuroplasticity. Ketamine also interacts with opioid receptors, particularly at the mu and kappa sites, which may contribute to its analgesic properties. Additionally, it has some activity at dopaminergic receptors and inhibits dopamine reuptake, leading to mild stimulant-like effects that can cause euphoria and increased motor activity.
Ketamine’s dissociative and hallucinogenic effects arise from its disruption of communication between the cortex and limbic system. The thalamus, which processes sensory information, becomes less responsive, while the default mode network (DMN), responsible for self-referential thinking and maintaining a stable sense of self, becomes desynchronized. This results in experiences of depersonalization, derealization, and in higher doses, full dissociation from the external environment. Users often report out-of-body experiences, distortions in time and space, and hallucinations ranging from visual distortions to complete immersion in dream-like states, commonly referred to as a "K-hole."
Physiologically, ketamine increases blood pressure and heart rate due to its sympathomimetic effects, making it different from most other anesthetics, which typically depress cardiovascular function. It also induces bronchodilation, which has led to its use in emergency medicine for patients with asthma or respiratory distress. Unlike other anesthetics, ketamine does not suppress respiration significantly, which contributes to its safety profile in medical settings.
At high doses or with frequent use, ketamine can lead to neurotoxic effects, including cognitive impairment and bladder toxicity. Chronic use has been associated with ketamine-induced cystitis, a severe inflammatory condition that can lead to bladder pain, frequent urination, and, in extreme cases, irreversible damage. The exact mechanism behind this toxicity is not fully understood but may involve direct effects on bladder epithelial cells and neuroinflammatory processes.
The combination of NBOMe compounds and ketamine would likely result in a highly unpredictable and potentially dangerous interaction due to their distinct but overlapping effects on neurotransmission.
At the serotonergic level this interaction could intensify hallucinations and create a dream-like or surreal state where reality feels unstable and fragmented. The sensory disruptions caused by ketamine, such as distortions in body awareness and time perception, might be amplified by the already powerful psychedelic effects of NBOMes, leading to an extreme dissociative-psychedelic state.
The risk of serotonin syndrome is a concern, as NBOMes are highly serotonergic and ketamine can increase serotonin activity indirectly. Excessive serotonergic stimulation can result in hyperthermia, agitation, muscle rigidity, and altered consciousness, which could be life-threatening. Additionally, both substances can contribute to significant cardiovascular strain. NBOMes are known to cause vasoconstriction and elevated blood pressure, while ketamine increases heart rate and blood pressure due to its sympathomimetic properties. Combining them may place excessive stress on the cardiovascular system, increasing the likelihood of hypertension, tachycardia, or, in extreme cases, cardiac complications.
Cognitively, this combination might produce severe confusion, dissociation, and disorganized thinking. Ketamine alone can induce thought fragmentation and detachment from reality, while NBOMes enhance sensory overload and unpredictable cognitive shifts. The result could be a state where perception becomes intensely disjointed, making it difficult to maintain any sense of control or coherence. Users might experience profound depersonalization, where they lose awareness of their identity or surroundings, or they may cycle between hyperconnected psychedelic states and deep dissociative voids.
Motor function would also be significantly impaired. Ketamine at moderate to high doses induces ataxia and muscle weakness, making movement difficult or impossible. NBOMes, on the other hand, can cause muscle tension, tremors, or restlessness. The combination could lead to a physically uncomfortable state where the user is unable to move properly but experiences intense internal stimulation, possibly contributing to feelings of panic or distress.
Psychological risks are heightened with this combination. NBOMes have been associated with anxiety, paranoia, and agitation, particularly at high doses, while ketamine’s dissociative effects can cause depersonalization and detachment. The unpredictable synergy between these two states could lead to extreme anxiety, psychotic-like experiences, or a sense of being trapped in an inescapable, chaotic mental space. Users prone to psychotic disorders or anxiety conditions may be particularly vulnerable to distressing or long-lasting psychological effects.
Given the lack of research on the specific interactions between NBOMes and ketamine, and considering the severe adverse effects associated with each substance individually, combining them is strongly discouraged due to the high potential for unpredictable and harmful outcomes.
Last edited by a moderator: